News Fundraising news

‘Barnesy’s’ Biography for Parkinson’s

Cure Parkinson’s would like to say a huge thank you to the inspirational Robert Barnes- known as ‘Barnesy’ by those closest to him- who has taken the time to write his first book ‘An Englishman Recalls: Memoirs of Robert Barnes’. In these heartwarming memoirs, Robert…


Type 2 diabetes medications impact risk of Parkinson’s

In a recent study, researchers have concluded that the elevated risk of Parkinson’s in patients with type 2 diabetes might be mitigated depending on the type of drugs prescribed to treat this type of diabetes.


News Research news

The 2020 International Linked Clinical Trials meeting

The International Linked Clinical Trials (iLCT) programme is the drug repurposing initiative focussed on identifying and clinically testing drugs that show potential in slowing or reversing the progression of Parkinson’s.


The 2020 Linked Clinical Trials meeting

Each year in September, The Cure Parkinson’s Trust and Van Andel Institute hold the international Linked Clinical Trials (iLCT) meeting. This is a drug-repurposing initiative focused on disease modification in Parkinson’s. For two days the iLCT committee discuss and debate the virtues of 20+ molecules to decide which should be prioritised […]


Press release

2020 Tom Isaacs Award honours leading Parkinson’s expert

25 September 2020 The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to announce Professor Caroline Tanner of University of California San Francisco’s Weill Institute for Neurosciences as this year’s deserving winner of the ‘Tom Isaacs Award’. The award was presented today…